Hyperthermic intraperitoneal chemotherapy (HIPEC) and cytoreductive surgery (CRS) in ovarian cancer: A systematic review and meta-analysis

European Journal of Surgical Oncology

Volumn 41, Issue 12, 2015, Pages 1578-1589

  Huo, Y R ^a,b   Richards, A ^b   Liauw, W ^c   Morris, D L ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

CRS; Cytoreductive surgery; HIPEC; Hyperthermic intraperitoneal chemotherapy; Meta analysis; Ovarian cancer; Review

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN; MITOMYCIN; PACLITAXEL; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RESISTANCE; CANCER SURGERY; CANCER SURVIVAL; COLON RESECTION; COMPARATIVE STUDY; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; FEMALE; HEMICOLECTOMY; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; HYSTERECTOMY; META ANALYSIS; MORBIDITY; OMENTECTOMY; OVARY CARCINOMA; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; RECTUM RESECTION; REVIEW; SALPINGOOOPHORECTOMY; SIGMOIDECTOMY; SMALL INTESTINE RESECTION; SPLENECTOMY; SURVIVAL RATE; SURVIVAL TIME; SYSTEMATIC REVIEW; OVARIAN NEOPLASMS; PROCEDURES;

ANTINEOPLASTIC AGENTS; CYTOREDUCTION SURGICAL PROCEDURES; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; OVARIAN NEOPLASMS;

EID: 84950312786     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.08.172     Document Type: Review

References (81)

1. M. Leitao Jr., and D.S. Chi Surgical management of recurrent ovarian cancer Semin Oncol 36 2009 106 111
2. D.K. Armstrong, B. Bundy, L. Wenzel, and et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 2006 43
3. G. Los, P.H.A. Mutsaers, W.J.F. van der Vijgh, G.S. Baldew, P.W. de Graaf, and J.G. McVie Direct diffusion of cis-diamminedichloroplatinum (II) in intraperitoneal rat tumors after intraperitonal chemotherapy: a comparison with systemic chemotherapy Cancer Res 49 1989 3380 3384
4. D. Armstrong, B. Bundy, L. Wenzel, and et al. Phase III randomized trial of intravenous cisplatin and paclitaxel versus an intensive regimen of intravenous paclitaxel, intraperitoneal cisplatin and intraperitoneal paclitaxel in stage III ovarian cancer: a Gynecologic Oncology Group Study N Engl J Med 354 2006
5. D. Tewari, J.J. Java, R. Salani, and et al. Long-term survival advantage and prognostic factors associated with intraperitoneal chemotherapy treatment in advanced ovarian cancer J Clin Oncol 33 13 2015 1460 1466
6. S.J. Chang, M. Hodeib, J. Chang, and R. Bristow Survival impact of complete cytoreduction to no gross residual disease for primary-stage ovarian cancer: a meta-analysis Gynecol Oncol 130 2013 493 498
7. W.J. Van Driel, C.A.R. Lok, V. Verwaal, and G.S. Sonke The role of hyperthermic intraperitoneal intraoperative chemotherapy in ovarian cancer Curr Treat Options Oncol 16 4 2015 1 14
8. R. Cavaliere, B.C. Giogatto, and B.C. Giovanella Selective heat sensitivity of cancer cells Cancer 20 1967 967
9. X.J. Yang, C.Q. Huang, T. Suo, and et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial Ann Surg Oncol 18 2011 1575 1581
10. T.D. Yan, D. Black, P.H. Sugarbaker, and et al. A systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer Ann Surg Oncol 14 2007 2702 2713
11. T.D. Yan, L. Welch, D. Black, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann Oncol 18 2007 827 834
12. V.J. Verwaal, S. Bruin, H. Boot, G. van Slooten, and H. van Tinteren 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer Ann Surg Oncol 15 2008 2426 2432
13. T.D. Yan, D. Black, R. Savady, and P.H. Sugarbaker A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei Ann Surg Oncol 14 2 2007 484 492
14. P.A. Cascales, J. Gil, P.J. Galindo, F. Machado, I.M.M. Frutos, and P.P. Paricio Heterogeneity in patients and methods. A problem for hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in ovarian carcinoma Eur J Obstet Gynecol Reprod Biol 158 2011 361 362
15. J. Spilioitis, E. Halkia, E. Lianos, and et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study Ann Surg Oncol 22 5 2014 1570 1575
16. P. Sugarbaker Peritonectomy procedures Ann Surg 221 1995 29 42
17. NHMRC How to use the evidence: assessment and application of scientific evidence 2000 National Health and Medical Research Council Canberra
18. P. Jacquet, and P. Sugarbaker Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis Cancer Treat Res 82 1996 359 374
19. W.J. Hoskins, W.P. McGuire, M.F. Brady, and et al. The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma Am J Obstet Gynecol 170 1994 974 980
20. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
21. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
22. M. Egger, G.D. Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test Br Med J 315 1997 629 634
23. R.G. Orwin A fail-safe N for effect size in meta-analysis J Educ Stat 8 1983 157 159
24. J.F. Le Brun, L. Campion, D. Berton-Rigaud, and et al. Survival benefit of hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer: a multi-institutional case control study Ann Surg Oncol 21 2014 3621 3627
25. K.S. Ryu, J.H. Kim, H.S. Ko, and et al. Effects of intraperitoneal hyperthermic chemotherapy in ovarian cancer Gynecol Oncol 94 2004 325 332
26. J. Gori, R. Castano, M. Toziano, and et al. Intraperitoneal hyperthermic chemotherapy in ovarian cancer Int J Gynecol Cancer 15 2005 233 239
27. J.H. Kim, J.M. Lee, K.S. Ryu, and et al. Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer J Surg Oncol 101 01 Feb 2010 149 155
28. R. Warschkow, I. Tarantino, J. Lange, and et al. Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients Patient Saf Surg 6 15 Jun 2012
29. A. Fagotti, B. Costantini, M. Petrillo, and et al. Cytoreductive surgery plus HIPEC in platinum-sensitive recurrent ovarian cancer patients: a case-control study on survival in patients with two year follow-up Gynecol Oncol 127 December 2012 502 505
30. F.C. Munoz-Casares, S. Rufian, M.J. Rubio, and et al. The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer Clin Transl Oncol 11 November 2009 753 759
31. T. Safra, D. Grisaru, M. Inbar, and et al. Cytoreduction surgery with hyperthermic intraperitoneal chemotherapy in recurrent ovarian cancer improves progression-free survival, especially in BRCA-positive patients-A case-control study J Surg Oncol 110 01 Nov 2014 661 665
32. N. Bakrin, J.M. Bereder, E. Decullier, and et al. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients Eur J Surg Oncol 39 December 2013 1435 1443
33. P.A. Argenta, T. Sueblinvong, M.A. Geller, and et al. Hyperthermic intraperitoneal chemotherapy with carboplatin for optimally-cytoreduced, recurrent, platinum-sensitive ovarian carcinoma: a pilot study Gynecol Oncol 129 Apr 2013 81 85
34. F. Cavaliere, P. Perri, F. Filippo, and et al. Treatment of peritoneal carcinomatosis with intent to cure J Surg Oncol 74 2000 41 44
35. W.P. Ceelen, Y. Van Nieuwenhove, S. Van Belle, H. Denys, and P. Pattyn Cytoreduction and hyperthermic intraperitoneal chemoperfusion in women with heavily pretreated recurrent ovarian cancer Ann Surg Oncol 19 July 2012 2352 2359
36. J. Delotte, T. Arias, O. Guerin, and et al. Hyperthermic intraperitoneal chemotherapy for the treatment of recurrent ovarian cancer in elderly women 2014
37. M. Deraco, S. Virzi, D. Lusco, and et al. Secondary cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer: a multi-institutional study BJOG 119 2012
38. E. Furet, E. Chereau, E. Lambaudie, M. Bannier, and G. Houvenaeghel Feasibility, morbidity and survival of surgery combined with HIPEC in the management of recurrent ovarian cancer Gynecol Obstet Fertil 41 Sep 2013 493 498
39. N. Carrabin, F. Mithieux, P. Meeus, and et al. Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer Bull Cancer 97 2010
40. F. Coccolini, L. Campanati, F. Catena, and et al. Hyperthermic intraperitoneal chemotherapy with cisplatin and paclitaxel in advanced ovarian cancer: a multicenter prospective observational study J Gynecol Oncol 26 2014 56 61
41. L. Gonzalez Bayon, M.A. Steiner, W. Vasquez Jimenez, and et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later? Eur J Surg Oncol 39 October 2013 1109 1115
42. E. Guardiola, D. Delroeux, D. Heyd, and et al. Intra-operative intra-peritoneal chemotherapy with cisplatin in patients with peritoneal carcinomatosis of ovarian cancer World J Surg Oncol 7 2009
43. M.C. Lim, S. Kang, J. Choi, and et al. Hyperthermic intraperitoneal chemotherapy after extensive cytoreductive surgery in patients with primary advanced epithelial ovarian cancer: interim analysis of a phase II study Ann Surg Oncol 16 April 2009 993 1000
44. R. Massari, M. Barone, R. Basilico, and et al. Peritonectomy and hyperthermic chemotherapy in patients with advanced or recurrent ephitelial ovarian cancer: a single center cohort study Minerva Chir 69 Feb 2014 17 26
45. M.J. Pavlov, P.A. Kovacevic, M.S. Ceranic, A.B. Stamenkovic, A.M. Ivanovic, and D.M. Kecmanovic Cytoreductive surgery and modified heated intraoperative intraperitoneal chemotherapy (HIPEC) for advanced and recurrent ovarian cancer - 12-year single center experience Eur J Surg Oncol 35 November 2009 1186 1191
46. T. Reichman, B. Cracchiolo, J. Sama, and et al. Cytoreductive surgery and intraoperative hyperthermic chemoperfusion for advanced ovarian carcinoma J Surg Oncol 90 2005 51 58
47. H. Muller An effective, multimodal therapy concept for the treatment of peritoneal metastasis of recurrent ovarian carcinoma Ein effektives, multimodales Therapiekonzept zur Behandlung des peritoneal metastasierten Ovarialkarzinom-Rezidivs [German] Dtsch Z Onkol 43 2011 11 18
48. P. Cascales-Campos, J. Gil, E. Feliciangeli, and et al. The role of hyperthermic intraperitoneal chemotherapy using paclitaxel in platinum-sensitive recurrent epithelial ovarian cancer patients with microscopic residual disease after cytoreduction Ann Surg Oncol 22 2015 987 993
49. C. Zanon, R. Clara, I. Chiappino, and et al. Cytoreductive surgery and intraperitoneal chemohyperthermia for recurrent peritoneal carcinomatosis from ovarian cancer World J Surg 28 2004 1040 1045
50. O. Zivanovic, A. Abramian, M. Kullmann, and et al. HIPEC ROC I: a phase i study of cisplatin administered as hyperthermic intraoperative intraperitoneal chemoperfusion followed by postoperative intravenous platinum-based chemotherapy in patients with platinum-sensitive recurrent epithelial ovarian cancer Int J Cancer 136 15 Feb 2014 699 708
51. L. Ansaloni, V. Agnoletti, A. Amadori, and et al. Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer Int J Gynecol Cancer 22 June 2012 778 785
52. A. Di Giorgio, E. Naticchioni, D. Biacchi, and et al. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer Cancer 113 15 Jul 2008 315 325
53. C.W. Helm, S.D. Richard, J. Pan, and et al. Hyperthermic intraperitoneal chemotherapy in ovarian cancer first report of the HYPER-O registry Int J Gynecol Cancer 20 January 2010 61 69
54. P. Piso, M.H. Dahlke, M. Loss, and H.J. Schlitt Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer World J Surg Oncol 2 28 Jun 2004
55. I. Konigsrainer, P. Horvath, F. Struller, and et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in recurrent epithelial ovarian cancer with peritoneal metastases: a single centre experience Langenbeck's Arch Surg 399 June 2014 589 594
56. M. Robella, M. Vaira, P. Marsanic, and et al. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC) Minerva Chir 69 February 2014 27 35
57. F. Roviello, E. Pinto, G. Corso, and et al. Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer J Surg Oncol 102 01 Nov 2010 663 670
58. A.A.K. Tentes, S. Kakolyris, D. Kyziridis, and C. Karamveri Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy in the treatment of advanced epithelial ovarian cancer J Oncol 1 2012 1 6
59. S. Rufian, F.C. Muñoz-Casares, J. Briceno, and et al. Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent or primary ovarian cancer J Surg Oncol 94 2006 316 324
60. F. Coccolini, E. Cotte, O. Glehen, and et al. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis randomized trials Eur J Surg Oncol 40 January 2014 12 26
61. J.A. Ledermann, F.A. Raja, C. Fotopoulou, A. Gonzalez-Martin, N. Colombo, and C. Sessa Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 24 2013 vi24 vi32
62. N. Colombo, M. Peiretti, G. Parma, and et al. ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 21 2010 v23 v30
63. E. Cotte, G. Passot, F. Mohamed, D. Vaudoyer, F.N. Gilly, and O. Glehen Management of peritoneal carcinomatosis from colorectal cancer current state of practice Cancer J 15 May-June 2009 243 248
64. M. Muller, M. Cherel, P.F. Dupre, S. Gouard, M. Collet, and J.M. Classe Cytotoxic effect of hyperthermia and chemotherapy with platinum salt on ovarian cancer cells: results of an in vitro study Eur Surg Res 46 April 2011 139 147
65. G. Grile The effects of heat and radiation on cancers implanted on the feet of mice Cancer Res 23 1963 372 380
66. R.E. Bristow, I. Puri, and D.S. Chi Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis Gynecol Oncol 112 2009 265 274
67. A.R. Munkarah, and R.L. Coleman Critical evaluation of secondary cytoreduction in recurrent ovarian cancer Gynecol Oncol 95 2004 273 280
68. E. Pujade-Lauraine, F. Hilpert, B. Weber, and et al. Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial J Clin Oncol 32 2014 1302 1308
69. D.G. Mutch, M. Orlando, T. Goss, and et al. Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer J Clin Oncol 25 2007 2811 2818
70. S.A. Cannistra, U.A. Matulonis, R.T. Penson, and et al. Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer J Clin Oncol 25 2007 5180 5186
71. P. Harter, A. Du Bois, M. Hahmann, and et al. Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial Ann Surg Oncol 13 2006 1702 1710
72. T.C. Chua, T.D. Yan, A. Saxena, and D. Morris Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality Ann Surg 249 6 2009 900 907
73. (7/5/15). Outcomes in CRS/HIPEC as initial treatment of ovarian, fallopian tube and primary peritoneal cancer. Available: https://clinicaltrials.gov/ct2/show/NCT02124421?term=hyperthermic+intraperitoneal&rank=8.
74. (7/5/15). Intraoperative hyperthermic intraperitoneal chemotherapy with ovarian cancer. Available: https://clinicaltrials.gov/ct2/show/NCT01091636?term=hyperthermic+intraperitoneal&rank=10.
75. (7/5/15). Secondary debulking surgery +/- hyperthermic intraperitoneal chemotherapy in stage III ovarian cancer. Available: https://clinicaltrials.gov/ct2/show/NCT00426257?term=hyperthermic+intraperitoneal&rank=13.
76. (7/5/15). Phase 3 trial evaluating hyperthermic intraperitoneal chemotherapy in upfront treatment of stage IIIC epithelial ovarian cancer (CHORINE). Available: https://clinicaltrials.gov/ct2/show/NCT01628380?term=hyperthermic+intraperitoneal&rank=17.
77. (7/5/2014). Hyperthermic intra-peritoneal chemotherapy (HIPEC) in ovarian cancer recurrence (HORSE). Available: https://clinicaltrials.gov/ct2/show/NCT01539785?term=hyperthermic+intraperitoneal&rank=7.
78. (7/5/15). Outcomes after secondary cytoreductive surgery with or without carboplatin hyperthermic intraperitoneal chemotherapy (HIPEC) followed by systemic combination chemotherapy for recurrent platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer. Available: https://clinicaltrials.gov/ct2/show/NCT01767675?term=hyperthermic+intraperitoneal&rank=2.
79. (7/5/15). Hyperthermic intra-peritoneal chemotherapy (HIPEC) in relapse ovarian cancer treatment (CHIPOR). Available: https://clinicaltrials.gov/ct2/show/NCT01376752?term=hyperthermic+intraperitoneal&rank=23.
80. (7/5/15). Cytoreduction with or without intraoperative intraperitoneal hyperthermic chemotherapy (HIPEC) in patients with peritoneal carcinomatosis from ovarian cancer, fallopian tube or primary peritoneal carcinoma (CARCINOHIPEC) Available: https://clinicaltrials.gov/ct2/show/NCT02328716?term=hyperthermic+intraperitoneal&rank=59.
81. Surgery and chemotherapy with or without chemotherapy after surgery in treating patients with ovarian, fallopian tube, uterine, or peritoneal cancer [Online]. Available: http://www.cancer.gov/clinicaltrials/search/view?cdrid=754204&version=HealthProfessional&protocolsearchid=13874015.